COVID-19 Expert Insights

Tom Kraus, vice president of government relations, ASHP, discusses the recent Department of Health and Human Services (HHS) announcement that allows inactive pharmacists along with pharmacy interns to join the vaccinator force—explaining that as the vaccine supply increases, these additional…

By Julie Gould  Richard Miller, MD, board-certified oncologist and adjunct clinical professor of Medicine (oncology) at Stanford University Medical Center, discusses a trial examining the use of CPI-006, a humanized monoclonal antibody that is designed to bind to and activate B cells, for the…

Michael Ganio, PharmD, senior director of Pharmacy Practice and Quality, ASHP, breaks down the importance of centralized leadership and clear onsite roles within mass COVID-19 vaccine locations, highlighting the pitfalls that should be avoided during the setup of these sites and how to prevent…

By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume 1, Issue 3  There is no "I" in team. As case counts continue to fall across the country, the recent approval of a third COVID-19 vaccine in the United States brings new hope to the fight against this calamitous pandemic. But…

By Tom Kraus, Vice President of Government Relations, ASHP  We’ve reached an important milestone in combatting the COVID-19 global pandemic: there are now three viable vaccines against SARS-CoV-2 in the US.  All three FDA-authorized vaccines have – based on the available evidence – proven…

By Yvette C Terrie, BS Pharm, RPh, Consultant Pharmacist Every day, health care professionals seem to learn a little more about COVID-19 as well as the medical conditions that may contribute to the severity of infection and the patient populations at greater risk for hospitalization due to severe…

By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS Volume 1, Issue 1 “Brevity is the soul of wit.” Welcome to the first installment of “Talking Therapeutics!” Each week we’re going to tackle a timely therapeutic topic by breaking it down into bite-sized talking points. The goal is to…

By Julie Gould  Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.   Can you talk a little about what is lacking in vaccine…

By Yvette C. Terrie B.S. Pharm, R.Ph., Consultant Pharmacist There is still great debate among many individuals about the efficacy and safety of COVID-19 vaccines and healthcare providers including pharmacists are likely to encounter many patients seeking their guidance and advice about the…

By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS In less than 12 months since the pandemic began, we have had two vaccines with Emergency Use Authorization from the FDA made available to the American public. This is truly a watershed moment for the scientific community as a whole, and…